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1. Introduction 
A seizure is defined as paroxysmal disturbances in neurological function of neurons which 
manifested clinically as alteration in motor, behavioral and/or autonomic functions. No 
period carry the danger of seizures to the individual person like the first four weeks of life 
because of immaturity of brain cell which render it more vulnerable to injury and because of 
wide range of problem that might cause seizures operate in this period. Neonatal seizures 
tend to be brief, because immature neurons are unable to sustain repetitive activity for long 
period of time and to be focal or multifocal. It requires immediate evaluation because of the 
variable conditions that might insult developing and vulnerable neurons of neonate, some 
of which might endanger the life of neonate. Some time seizures might be the first and 
probably the only manifestations of underlying significant dysfunction of CNS of newborn 
infant. Furthermore, these seizures are sometime difficult to be diagnosed clinically 
resulting in delaying treatment and worsening short and long term prognosis. There is still a 
great debate about pathophysiology, clinical classification, EEG significance and treatment 
of neonatal seizures.  
2. Incidence 
Neonatal seizures are common: and the incidence is variable according to age and maturity 
of the neonate, weight and the severity of the underlying condition. The real incidence has 
not been established clearly, although it had been estimated that the incidence rate of 
clinical seizures varies from 1.1 to 8.6 per 1000 live births (1 - 3). Preterm newborn exhibits 
higher risk for neonatal seizures than term newborn and both lower birth weight and 
gestational age confers increased risk (2, 4, 5). In term infant the incidence range from 0.7 to 2.7 
per 1000 live births and from 57.5 to 132 per 1000 live births in preterm infants (6,7). In those 
weighing less than 1,500 g, the incidence ranges from 19 to 57.5 per 1,000 live births, While in 
infants who's weight more than 2,500 g, the incidence is as low as 2.8 per 1,000 live births (3). 
Scher and colleagues reported that seizures occurred in 3.9% of neonates of less than 30 
weeks’ conceptional age and 1.5% in neonates older than 30 weeks (8, 9). Additionally, 
seizures may account for up to 3.4 % of all admission to neonatal intensive care unit (7).  
3. Pathophysiology  
A clinical seizure results from excessive synchronized depolarization of the neurons within 
the central nervous system resulting in excessive synchronous electrical discharge. Why this 
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excessive depolarization of the neurons might occur remains unknown. Theories were 
suggested include the following:  
1. Imbalance between excitatory and inhibitory neurotransmitter like excessive excitatory 
amino acid (e.g. glutamate) or deficient inhibitory neurotransmitter (e.g. Gama Amino 
Butyric Acid, GABA) (10). 
2. Failure of energy production due to disruption of ATP dependent resting membrane 
potentials resulting in failure of sodium potassium pump which in turn leading to 
movement of sodium into the neuron and potassium out of the neuron.(11,12) 
3. Neuronal hyper excitability state in the neonatal period, as evidenced by the extremely 
low threshold to seizures in general and that this is the period of highest incidence of 
seizures across the life span (13, 14). Among the factors that cause increase excitability are 
incomplete myelination and neuropeptides particularly corticotrophin releasing 
hormone (CRH) (15, 16). 
4. Experimental and clinical evidence exists for early microglial activation and 
inflammatory cytokine production in the developing brain in both hypoxia/ischemia 
(17,18) and inflammation (19,20) Importantly, microglia have been shown to be highly 
expressed in immature white matter in rodents and humans during cortical 
development (21). 
5. Genetic predisposition as most of the cases of Benign Familial Neonatal Seizures (BFNS) 
are due to mutations in two genes, KCNQ2 and KCNQ3, which encode subunits of a 
type of voltage-gated potassium ion (Kv) channel. Of about 70 BFNS families so far 
studied genetically, 60% have mutations in KCNQ2, and 5% have mutations in KCNQ3. 
The cause in the remaining cases is unknown. Some are likely due to mutations in 
portions of the KCNQ2 and KCNQ3 genes that do not encode amino acids but may 
affect channel expression (e.g., enhancers, promoters, introns). It is possible that one or 
more additional BFNS genes remain undiscovered (22).  
6. Idiopathic as in the cases of Benign Non Familial Neonatal Seizures (BNFNS), also 
called fifth day disease were the pathophysiology remains unknown (23, 24).  
4. Causes 
The causes of neonatal seizures are divers and voluminous. It covers the entire spectrum of 
neurological disorders of the newborn. In practice, knowing the cause is vital for 
neonatologist regarding therapeutic and prognostic issues. For example, neonatal seizures 
due to transient metabolic disorders of newborn like hypocalcemia and hypoglycemia are 
easily to be treated by correction of metabolic derangement and are usually associated with 
favorable outcome regarding neurodevelopment and future epilepsy risk. In contrast, 
neonatal seizures caused by structural abnormalities of the brain are difficult to control and 
associated with poor outcome. The causes of neonatal seizures can be grouped under the 
following heading (table 1):  
 
1. Brain insults 
a. Hypoxic ischemic encephalopathy 
b. Intracranial infections 
c. Intracranial hemorrhage 
www.intechopen.com
 Neonatal Seizures 29 
d. Cerebrovascular infarction 
e. Structural malformation of brain 
2. Metabolic disorders 
a. Hypocalcemia 
b. Hypoglycemia 
c. Hyponatremia 
d. Hypernatremia 
e. Pyridoxine deficiency 
3. Inborn error of metabolism 
a. Urea cycle disorder 
b. Aminoacidopathies 
c. Biotinidase deficiency 
d. Mitochondrial disorder 
e. Defects in beta oxidation 
f. Glucose transporter deficiency 
g. Peroxisomal disorder 
h. Pyridoxine deficiency 
i. Non ketotic hyperglycinemia 
4. Neonatal epileptic syndrome 
a. Benign idiopathic neonatal seizures 
b. Benign familial neonatal seizures 
c. Ohtahara's syndrome 
d. Early myoclonic encephalopathy 
5. Miscellaneous 
a. Polycythemia 
b. Accidental local anesthetic drug injection 
c. Withdrawal syndrome 
d. Drug toxicity 
Table 1. Causes of neonatal seizures 
1. Brain insults: hypoxic ischemic encephalopathy is the most common cause of neonatal 
seizures accounting for about two third of all cases (25, 26). The seizures are usually begin 
within the first 24 hours after birth and are associated with obtundation (27, 28, and 29). In 
one study, 60% of these neonates developed seizures within the first 12 hours (30). The 
frequency and the severity of seizures are usually parallel to the severity of the 
encephalopathy and about one third of them will be epileptic in the future (25). The 
seizures types include subtle (the most common), focal and multifocal clonic and 
myoclonic. Intracranial infection account for 5 to 10 % of seizures (31). Could be acquired 
prenatally or postnatally and it is more common in developing countries. Bacterial 
meningitis usually causes seizures later in the first post natal week (late onset) (32), the 
most common bacterial pathogens are group B streptococci, listeria, Escherichia coli and 
other gram negative bacteria. Congenital infection caused by such pathogen as 
toxoplasmosis, rubella and CMV virus may cause seizures which may be the sole 
manifestation but it usually tend to occur later in the neonatal period or early infancy. 
Encephalitis caused by various viruses such as herpes simplex virus (HSV) and 
enteroviruses may cause seizures. Some of these viruses acquired from birth canal 
during labor and other from the environment. HSV encephalitis is one of the most 
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important viruses causing encephalitides in the neonatal period. Seizures tend to occur 
in 57% of neonate who have CNS disease and 22% of neonate who have the 
disseminated form of the disease but rarely in the skin eye mouth disease form (33). The 
neonatal form of HSV encephalitis is caused more often by type 2 HSV that the 
newborn acquires during delivery from maternal genital lesions. Fetal scalp monitoring 
may be a risk factor for acquiring the virus. Neuroimaging studies in neonatal HSV 
encephalitis often show diffuse brain abnormalities (25). Because of the severity of the 
condition and poor outcome, any patient with neonatal seizure and suspected to have 
neonatal HSV, appropriate diagnostic tests should be obtained and the empirical 
acyclovir therapy should be initiated immediately. Intracranial hemorrhage account for 
about 10% of all cases of neonatal seizures (27). In preterm infants, small intraventricular 
hemorrhage limited to the germinal matrix do not result in seizures, usually they 
present with poor activity and feeding with unexplained drop of hematocrit. When the 
hemorrhage is extensive, the seizures are a common correlates and may account for 45% 
of preterm infants who had EEG documented seizures (28). Persistent tonic seizures are 
the most typical but subtle seizures can also occur. They commonly occurs between 3-7 
days of age (32). In full term neonates, subarachnoid, subdural and intraparenchymal 
hemorrhage are common causes. Subarachnoid hemorrhage tends to occur in healthy 
looking full term infant delivered vaginally. Classically seizures occur in the second day 
and have been named as well –baby with seizures (34). They resolve rapidly with good 
prognosis. On the other hand, subdural hematomas are usually results from trauma and 
commonly associated with cerebral contusion. Focal rather than multifocal seizures are 
common and they tend to occur in the first two post natal days. Subdural hematoma 
after the second day of life in a neonate who was discharged from hospital should raise 
the possibility of non accidental injury. Cerebrovascular infarction is another cause of 
neonatal seizures and it can results from both arterial and venous occlusion. Arterial 
occlusion causes infarction of area supplied by a single artery. The middle cerebral 
artery is most frequently involved. Risk factors include trauma, congenital heart 
disease, coagulopathy and metabolic disturbances. Arterial occlusion leads to 
porencephalic cyst which in cases of multiple vascular involvement can leads to 
encephalomalacia and hydraencephaly. Focal neurological seizures are common and 
the neonate has abnormal neurological examination. The severity and localization of 
seizures are variable according to the location and the extent of infarction. On the other 
hand, cerebral venous thrombosis might result in seizures in 68% (35). The occlusions 
usually occur in the superior saggital sinus, sigmoid/transverse sinus or multiple 
venous sinuses (25). Polycythemia, dehydration, persistent pulmonary hypertension, 
infections, thrombophilic disorders and Extracorporeal membrane oxygenation (36, 37) 
are among the documented risk factors for venous thrombosis. Structural malformation of 
the brain is another cause for neonatal seizures. In one study they account for 1.8% of 
studied cases (38). Fifty percent of patients with holoprosencephaly (failure of complete 
separation of cerebral hemispheres and deep gray nuclei) have neonatal seizures (39). 
Lissencephaly (malformation of the brain in which the cortical surface is smooth or 
contain thick broad gyri) is commonly associated with seizures which are usually 
refractory to treatment (40). Cerebral dysgenesis and neuronal migration disorders are 
rare causes of seizures in the neonatal period, they may be caused by a specific inborn 
error of metabolism that disturbs early fetal development. For example, nonketotic 
hyperglycinemia, pyruvate dehydrogenase deficiency, and maternal hyperglycinemia 
frequently are associated with corpus callosal dysgenesis while peroxisomal disorders 
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and fatty acid oxidation defects have been associated with migration abnormalities (25, 
41). Neurocutaneous syndromes like tuberous sclerosis and Sturge Weber syndrome 
might also present neonatal seizures.  
2. Metabolic disorders: can also cause neonatal seizures. The severity of neurological 
symptoms is directly correlated with the duration of metabolic disturbances (42). 
Hypocalcemia nowadays account for about 3% of all cases of neonatal seizures, mostly 
are focal and occurs in the first 72 hours of life (29, 43). Most common causes are low 
birth weight especially those associated with intrauterine growth retardation, infants of 
diabetic mothers, and hypoxic ischemic encephalopathy. The incidence of hypocalcemia 
is inversely proportional to gestational age and birth weight. Other causes of 
hypocalcemia include maternal hypercalcemia, primary hypoparathyroidism, X linked 
hypoparathyroidism and DiGeorge syndrome (43). Hypomagnesaemia often associated 
with hypocalcemia, but it does not seem to cause seizures in isolation without 
hypocalcemia (25). One study shows that approximately 50% of cases being associated 
with congenital cardiac defects which if present should raise the possibility of particular 
causes of hypocalcemia such as DiGeorge syndrome (44). Hypoglycemia is another 
cause of neonatal seizures; common causes include intrauterine growth retardation, 
prematurity, infant of diabetic mothers, birth asphyxia, intracranial hemorrhage and 
infection. The most common symptoms of hypoglycemia in intrauterine growth 
retardation, in addition to seizures, are jitteriness, hypotonia, stupor and coma (45). 
Seizures and other neurological symptoms are rapidly relieved by correction of 
hypoglycemia. Failure of relieving seizures and hypoglycemia after adequate correction 
should raise the possibility of underlying metabolic or endocrine problems. 
Hyponatremia, hypernatremia and pyridoxine deficiency can also produce neonatal 
seizures but are less common.  
3. Inborn errors of metabolism: are relatively rare causes of neonatal seizures. They 
should be suspected in any healthy neonate who deteriorates and develop 
encephalopathy and seizures after initiation of feedings. Metabolic disorders that can 
cause neonatal seizures include urea cycle disorder, aminoacidopathies, biotinidase deficiency, 
mitochondrial disorders, defects in beta oxidation, glucose transporter deficiency and 
peroxisomal disorder. Disturbances of amino acid or organic acid metabolism are often 
the most common inborn errors of metabolism that present with neonatal seizures (42). 
Some of these disorders are treatable and some are not. Pyridoxine dependency is a rare 
disorder of pyridoxine metabolism , that produces sever seizures in the first few days of 
life and are resistant to antiepileptic drugs but can controlled with high dose of 
intravenous pyridoxine (46-50). On the other hand neonatal non-ketotic hyperglycinemia 
(glycine encephalopathy) is a rare non treatable cause of neonatal seizures due to a 
defect in cleavage of the excitatory amino acid glycine. It usually present with 
myoclonic seizures in the second or third day of life associated with static 
encephalopathy (51).  
4. Neonatal epileptic syndromes: these includes benign idiopathic neonatal convulsions or 
called fifth day fits which was first described by Dehan and colleagues in 1977 (52). They 
may account for as many as 5% of seizures in the full term neonates (42). It usually 
appears in otherwise healthy full term infants in the first week of life (mostly 4-6 days) 
and resolve within 24 to 48 hours after onset. The seizures are usually brief (1 to 3 
minutes) but rarely prolong and might end with status epilepticus. They are mostly 
focal clonic and rarely focal tonic, fluctuating between right and left, and the infant is 
normal between the attacks. History and examination of neonate is normal, family 
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history is negative and they have no subsequent increase risk of epilepsy but some 
studies report increased risk of minor neurological impairment ( 53,54). The etiology 
remain unknown, many theories had been postulated including zinc deficiency (55), 
rotavirus infection (56) and mutations in the neuronal potassium channels KCNQ2 (57), 
but none were confirmed. The interictal EEG shows a theta pointu alternant pattern. 
The EEG background consists of predominantly sharply contoured theta (4 to 7 Hz) 
activity that is discontinuous and intermixed with other sharp activity (25). The diagnosis 
is that of exclusion and the treatment with anticonvulsant is controversial. Benign 
familial neonatal convulsions are rare disorder of autosomal dominant inheritance with 
incomplete penetrance, usually occurs in the first week of life after an initial seizure – 
free period. The neonate is otherwise healthy but with family history of neonatal 
seizures (58-60). The seizures are focal clonic or focal tonic, sometimes associated with 
apnoeic spells or eye deviation to one side. The interictal EEGs can be normal, but ictal 
findings typically consist of an initial electrodecremental event (flattening of the EEG) 
followed by bilateral spike and slow wave discharges, often accompanied by rhythmic 
clonic activity (59). Two chromosomal loci were implicated: one on chromosome 20q13(61) 
and one on chromosome 8q(62-64) and the Genes responsible for this disorder are 
potassium channel genes, referred to as KCNQ2 for the chromosome 20q gene (65,66) and 
KCNQ3 for the chromosome 8q gene(64). There is no consensus on the treatment, some 
use phenobarbital to control acute seizures and continued for the first 3 months (22). Two 
sever catastrophic epileptic syndromes have also been identified in the neonatal period 
namely Ohtahara's syndrome and early myoclonic encephalopathy. Both can present 
with seizures shortly after birth usually in the first 10 days. The infants with these two 
encephalopathies have sever neurological disease, with developmental delay and 
intractable seizures (42). Seizures in Ohtahara's syndrome characterized by frequent tonic 
spasms (100-300 per day) often in clusters(67)and the EEG characterized by burst 
suppression pattern, both in sleep and waking. The etiology is usually related to 
malformation of cortical development like Aicardi syndrome or porencephaly. The 
seizures are resistant to treatment and the prognosis is poor and they may evolve into 
infantile spasms. On the other hand, seizures in early myoclonic encephalopathy 
characterized initially by fragmentary myoclonic jerk which replaced later by partial 
seizures, massive erratic myoclonus and infrequently tonic seizures (25). The EEG 
characterized by burst suppression pattern, with periods of suppression (4-12 sec) that 
are seen during sleep (68). The etiology may be related to inborn error of metabolism 
especially propionic academia, non ketotic hyperglycinemia and D-glyceric acidemia (68-
70). The seizures are resistant to treatment, the infants are severely neurologically 
abnormal and they may die early in the first year of life.  
5. Miscellaneous: cause include polycythemia, accidental local anesthetic drug injection in 
the scalp, withdrawal syndromes associated with maternal drug use, and the drug 
toxicity like theophylline. Recently, neonatal seizures provoked by electrolyte 
abnormalities secondary to dehydration and renal failure from intestinal obstruction 
secondary to congenital duodenal atresia had been reported (71). 
5. Clinical manifestations and classification 
Clinically neonatal seizures are different in manifestations and classification when 
compared with older infants, children and adult. The reasons for this difference are related 
to difference in mechanisms causing seizures in immature brain and incomplete myelination 
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of neurons. Most seizures are subtle, difficult to be recognized and can easily be mistaken 
for common normal rhythmic and jerky neonatal behaviors. It might be fragmented, 
disorganized with abnormal spread leading to a multi focal appearance. Generalized tonic 
clonic seizures are very rare if ever occur in neonatal period because the arborization of 
axons and dendritic processes as well as myelination is incomplete in the neonatal brain. A 
seizures discharge, therefore, cannot readily be propagated throughout the neonatal brain to 
produce a generalized seizure (72). The five clinical types of neonatal seizures adopted by 
Volpe (73) are the most widely accepted classification, these include; 
Subtle: are the most common type in both term and preterm neonates, constitute about 50% 
of all neonatal seizures. Usually they manifest as mild paroxysmal alteration in behavioral, 
motor or autonomic function that are not clonic, tonic or autonomic and they are commonly 
missed or mistaken for normal neonatal behavior. They are often originated in subcortical 
area and have no EEG correlate. The most common manifestations are:  
 Ocular: are the most common clinical findings in both term and preterm neonates. They 
are usually consisting of staring, horizontal or vertical sustained deviation of the eyes or 
eye blinking. 
 Oral: can manifest as swallowing movement, tongue thrust, lip smacking or chewing 
movement. 
 Limb: manifest as bicycling of legs, boxing or swimming movement of the arms or other 
stereotypic limb movement.  
 Autonomic: include alteration in blood pressure and/or heart rate, excessive salivation, 
pupillary dilatation and central apnea associated with tachycardia.  
 Apnea: is a rare manifestation of neonatal seizures, commonly associated with normal 
or exaggerated heart rate when evaluated within 20 second after the onset. It is more 
common in term infant and usually associated with eye signs. Apnea alone in 
preterm neonate should raise the possibility of other underlying problem than 
neonatal seizures.  
Most of subtle seizures occurs in combination and prolong video EEG monitoring failed to 
demonstrate any associated abnormal electrographic discharge (27, 74). 
Clonic: are more common in term than preterm neonates and usually associated with 
electrographic seizures. They involve abnormal slow rhythmic movement of group of 
muscles of face, neck, limbs or trunk involving one side of body or both sides 
simultaneously in a non synchronous manner.  
Multifocal clonic: are clonic seizures occurring in several parts of the body. Also they are 
seen primarily in term neonates figure 1.  
Clonic and multifocal clonic are easily to be diagnosed clinically but sometime they may be 
difficult to be differentiated from non epileptic movement s like jitteriness.  
Tonic: they involve sustained flexion or extension of axial or appendicular muscles groups. 
It could be focal or generalized. The generalized tonic seizures can result in a posture 
resemble that of decerbrate (tonic extension of all limbs) or decorticate (tonic flexion of 
upper limbs and tonic extension of lower limbs). The generalized tonic seizures are usually 
associated with normal EEG tracing. On the other hand, focal seizures are characterized by 
sustained posturing of single limb or sustained a symmetrical posturing of the trunk or eyes 
usually accompanied by apnea, flushing or cyanosis. Usually the EEG is abnormal in focal 
tonic seizures (75).  
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Fig. 1. Multifocal clonic fit with involvement of muscle of face, neck, trunk and limbs. 
Written informed consent was obtained from parents. 
Myoclonic: these manifests as random single rapid contraction of groups of muscle the 
limbs, face, or trunk. It might be generalized, focal or fragmentary (75). Occurrence at more 
rapid speed and predilection for flexor group of muscles can distinguish it from clonic 
seizures. EEG might be normal or shows changes including burst suppression pattern, focal 
sharp wave and hypsarrhythmia. If the myoclonus is related to sleep or hypoxic ischemic 
injury, the EEG shows no abnormal changes (27, 30, 76). Myoclonic neonatal seizures carry the 
worst prognosis regarding the neurodevelopmental out come and some of it might progress 
to infantile spasm. 
These clinical types of neonatal seizures should be differentiated from the more common 
repetitive, rhythmic and jerky movement made by normal newborn. Provoking by 
stimulation, elimination by passive flexion or soothing touch and presence of normal heart 
rate of value in differentiation.  
Other classification of neonatal seizures depends on correlation between clinical events and 
occurrence of electrical seizures activity on EEG trace 
 Electroclinical: when the clinical events overlaps in time with electrographic seizures 
activity.  
 Clinical only: when the clinical events occurs in the absence of any EEG seizures 
activity. It's significant is not clear.  
 Electrographic only: EEG shows electrical seizures without any coincidental clinical 
seizures activity. There is evidence that they have a similar impact on long term 
outcome as electroclinical seizures (77.78). 
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6. Investigations  
Neonatal seizures are one of the neonatal emergencies that are required urgent treatment 
and evaluation. Because of the wide range of differential diagnosis, investigations should be 
guided by history and clinical examination but some investigations should be obtained in 
nearly all neonates with seizures. These investigations include basic biochemistry test, CSF, 
neuroimaging and EEG. Other tests might not be needed routinely and are suggested by 
history and clinical examination such as screening for TORCH, inborn error of metabolism 
and intoxications. The goal of determining the cause of neonatal seizures is to treat and 
prevent cases and to determine the prognosis. The investigations can be grouped under the 
following heading:  
 Septic screen: because infections are common and readily treatable cause of neonatal 
seizures, investigations such as blood culture, urine culture and CSF analysis should 
urgently obtained when we suspect such cases as meningitis, ventricullitis and brain 
abscess. In such cases, empirical antibiotics should be started pending the results of 
investigations. When viral encephalitis is suspected especially herpes simplex virus, 
investigations including PCR and viral culture for HSV should be obtained while the 
neonate is empirically treated with antiviral agent such as acyclovir. 
 TORCH screening: should be considered in any neonate with seizures and stigmata of 
congenital infection as micro or hydrocephaly, hepatosplenomegaly, skin rash, small for 
gestational age, thrombocytopenia and chorioretinitis.  
 Metabolic screen: including serum electrolyte (Na, Ca, and Mg), blood sugar, arterial 
blood gas, anion gap, urine pH and reducing substances, blood ammonia for urea cycle 
abnormalities, urine and serum aminoacidogram, serum and CSF lactate/ pyruvate 
ratio and screening test for various inborn error of metabolism. A persistent metabolic 
acidosis suggests an organic acidemia.  
 Neuroimaging: these investigations can detect neonatal strokes, structural 
abnormalities, intraventricular hemorrhage and neuronal migration defects. It includes 
skull X ray, ultrasound, CT scan and MRI. The choice of neuroimaging is frequently 
debated (25). Skull X ray is of limited value but can shows intracranial classification in 
suspected TORCH infection. Cranial ultrasound is the test of choice when the patient is 
in critical condition and he or she suspected to have intracranial pathology. The 
advantages are that it is readily available in most centers, can be done at bedside and in 
most of the time there is no need for anesthesia but it is limited by its low resolution 
and its ability to assess cerebral cortex. CT scan is very helpful to exclude intracranial 
hemorrhage, infarction, structural abnormalities of the brain and hydrocephaly. MRI is 
indicated when other tests not revealed the underlying pathology and the seizures is 
refectory to antiepileptic drugs. It can be diagnostic in Lissencephaly, cerebral 
dysgenesis, neuronal migration defects and it’s the study of choice for pattern of 
hypoxic ischemic brain injury (25). For symptomatic seizures cause by HIE, abnormal T2, 
fluid attenuated inversion recovery, and diffusion signals can be used to pinpoint 
regional injury and severity (79). Some studies revealed that magnetic resonance 
spectroscopy can be used to predict the severity and prognosis in those patients (80, 81).  
 Electroencephalography: It should be done in all neonates with seizures requiring 
anticonvulsant therapy. It has both diagnostic and prognostic value. The EEG 
definitions vary, but paroxysms are considered to be seizures if they last more than 10 
seconds (82). The typical duration of the electrographic neonatal seizures is 2-3 minutes 
(83) but many seizures is shorter particularly in preterm infants (84). Although focal sharp 
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waves may be present interictally in the neonatal EEG, they are not considered 
epileptiform. Some focal sharp waves are normal features of the neonatal EEG, such as 
frontal sharp transients and some temporal sharp waves (85). On the other hand, not all 
neonatal seizures have abnormal EEG pattern, because of immaturity of the brain and 
interictal scalp recording may fail to pickup seizures activity especially those originated 
at subcortical level and are not propagated to surface electrodes (86) or some subtle and 
tonic seizures might not be epileptic but are primitive brain stem and spinal motor 
phenomena (76). There is often poor correlation between the electrographic and clinical 
manifestations of neonatal seizures (87). The background EEG activity can provide 
information concerning degree of associated central nervous system dysfunction, 
potential risk of seizures and prognosis. The degree of abnormality of the interictal 
background activity may suggest the extent and type of CNS dysfunction associated 
with seizures. The nature of the interictal background activity may also indicate the 
potential risk the individual infants have in experiencing a seizure (85, 88). Video EEG 
monitoring has proved to be a powerful tool in diagnosis and management of neonatal 
seizures and as well as in clinical research. It is now becoming more available at many 
centers for routine use and more widely employed in neonatal intensive care units (85).  
7. Diagnosis 
Diagnostic evaluation for neonates with seizures should be performed in a stepwise manner 
starting with exclusion of conditions that might simulate seizures. Jitteriness is the most 
common neonatal movement that might mistaken for seizures. It is due to cerebral 
excitability and usually mimics clonic seizures. Common causes include hypocalcemia, 
hypoglycemia, hypoxic ischemic encephalopathy; infant of diabetic mother, polycythemia, 
drug withdrawal or idiopathic were no cause can be identified. It consist of fast tremor of 
one or more extremities that can be easily differentiated from seizures by the facts that it can 
be provocated by stimulation of the infant or stretching of a joint, terminated by holding or 
passive flexion of the limb, absence of eye signs, absence of autonomic changes especially 
tachycardia and finely by absence of EEG correlate. Benign neonatal sleep myoclonus is more 
commonly occur in preterm. The mechanism is unknown but might be related to a transient 
dysmaturity of the brain stem reticular activating system (87). It present in the first week  
of life, always in sleep during rapid transmission from wakefulness to REM sleep or from 
REM to quite sleep. It might be induced by stimulation associated, commonly associated 
with sucking or stretching activities and can be rapidly abolished by arousal. The EEG is 
normal. Apnea especially if occur alone in preterm infant might be due to causes other than 
neonatal seizures. It usually associated with bradycardia in contrast with seizures where 
tachycardia is common. Opisthotonos consist of prolong arching of the back, might be 
mistaken for tonic seizures but absence of abnormal eye movement is useful for 
differentiation. Common causes include meningitis, intracranial hemorrhage and 
kernicterus. Neonatal hyperekplexia also known as startle disease, hyperekplexia is a rare 
disorder characterized by generalized muscle rigidity in the neonate, nocturnal myoclonus 
and an exaggerated startle reaction to auditory, tactile and visual stimuli. The startle 
reaction is a normal response to stimuli that consists of facial grimace and blinking followed 
by flexion of the trunk. The startle response is exaggerated when it interferes with normal 
activities, and causes apnea and frequent falls (89). 
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8. Treatment  
The most important factor in determining the treatment in neonatal seizures is the 
recognition of underlying cause of the seizure. Some cases require only correction of the 
associated metabolic disturbances like hypocalcemia or hypoglycemia without the need for 
anticonvulsant drugs. On the other hand, some refractory cases require multiple 
anticonvulsant therapy in combination. Some causes of neonatal seizures may have more 
than one mechanism in producing seizures as in cases of hypoxic ischemic encephalopathy 
were brain injury and metabolic disturbance might play a role in producing seizures. This 
fact should be taken in consideration while managing a neonate with seizure.  
There is a great debate whether a clinical – electrographic correlation is necessary to start 
vigorous treatment with anticonvulsant medication. Animal data indicate that both clinical 
and electrographic seizures may have long term behavioral and cognitive consequences on 
the immature brain. This may indicate aggressive anticonvulsant treatment for all seizures. 
Treatment of newborn with seizure involves:  
1. General supportive measures: basic medical emergency principles should be applied to 
establish airway and breathing and to maintain circulation. Oxygen should be given if 
the seizures are prolonged and an intravenous line access should be secured for 
administrations of drugs and drawing blood for baseline investigations.  
2. Treatment of associated metabolic disturbances:  
2.1 Hypocalcemia: should be treated by slow intravenous infusion of 2ml/kg of 10% Ca 
gluconate at a rate of 1 ml/minute under strict monitoring heart rate. The dose can be 
repeated in 10 minutes if no response occurs. If ionized calcium level is suggestive of 
hypocalcemia, the Ca gluconate should continue for 3 days at a rate of 8 ml/kg/day. If 
despite of correction of serum calcium the neonate continue to have seizures, 0.2 ml/kg 
of 50% magnesium sulphate (50 mg/kg) should be given intramuscularly. The dose can 
be repeated every 12 hours until normalization of serum magnesium is achieved.  
2.2 Hypoglycemia: animal studies revealed that glucose administration just before seizures 
prevents the decrease in brain glucose level that occurs with status epilepticus and 
markedly decrease mortality and neuronal cell loss (90). Blood glucose should be 
obtained immediately and if there is hypoglycemia, 2 ml/kg bolus of 10% glucose in 
water should be given followed by continuous infusion of glucose at a rate of 6-8 
mg/kg/minute. It is important to avoid hyperglycemia by frequent checking of blood 
glucose.  
2.3 Pyridoxine dependency: dramatic response to intravenous 100 mg of pyridoxine used 
empirically in refractory seizures is highly suggestive of pyridoxine dependency this 
can be confirmed by continuous EEG monitoring.  
2.4 Anticonvulsant: if the seizures persist or are recurrent, anticonvulsant drugs should be 
started. The most widely used drug for neonatal seizures is phenobarbitone which 
together with benzodiazepines (diazepam and lorazepam) and phenytoin (or 
Fosphenytoin) regarded as first line therapy (table 2).  
Phenobarbitone: is the drug of choice for neonatal seizures by most centers. It is given as 
initial intravenous loading dose of 20 mg/ kg. If the seizure is persist after completions the 
loading dose, repeated doses of 5-10 mg/ kg every 20-30 minute until a clinical response or 
maximum dose of 40 mg / kg has been given. The highest therapeutic serum level of 180 
µmol/L should not be exceeded. The maintenance dose is 3 – 5 mg/kg/day in 1-2 divided 
doses, started 12 hours after the loading dose. Careful monitoring of cardiac and respiratory 
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function is necessary. Some studies, using continuous video EEG monitoring reveals a 
clinical control in only 30-40% (91, 92). The reminder might experienced a reduction in the 
electro-clinical seizures but increased the number of electrographic seizures (92, 93). The use of 
phenobarbitone as prophylactic for neonatal seizures in birth asphyxia is debatable. One 
study reveals a better neurodevelopmental outcome at 3 years of age after 40 mg/kg 
phenobarbitone used as prophylactic in a term neonates with perinatal asphyxia (94). 
Another study revealed immediate adverse effects to phenobarbital used as prophylactic 
therapy in term newborn with perinatal asphyxia at a dose of 10 mg/kg (95). The 
phenobarbitone should be used for the shortest possible period of time because of the 
possibility of phenobarbital induced neurodegeneration, inhibition of brain growth and 
impaired cognition and behavior (96, 97).  
 
Drug Rout Dose 
First line drugs 
 Phenobarbitone IV 
 
Loading 20 mg/kg 
Maintenance 3 – 5 mg/kg/day 
 Phenytoin 
IV infusion 
Loading 20 mg/kg 
Maintenance 2 – 3 mg kg/day 
 Benzodiazepines 
                Diazepam 
 
IV injection , 
infusion or 
rectal 
 
0.3 mg /kg bolus followed by 
o.3 mg/kg/hour infusion 
0.5 mg/kg rectally 
                Lorazepam IV injection 0.05 – 1 mg/kg 
                midazolam 
IV injection 
and infusion
Loading 0.15 mg/kg followed by infusion 
0.1 – 1.4 mg/kg/hour 
Second line drugs 
 Lidocaine  IV infusion 
 
Loading 2 mg/kg followed by 4 – 6 
mg/kg/hour 
 Levetiracetam Oral 
Intravenous
Initial dose 10 mg/kg increased to 30 
mg/kg 
 Carbamazepine  
Oral 
10 mg/kg initially followed by 15 – 20 
mg/kg/day 
 Valproic acid intravenous , 
rectal 
Loading 20 – 25 mg/kg/day followed by 5 
– 10 mg/kg/12 hourly 
 Vigabatrin  Oral 50 mg /kg/day 
Table 2. Anticonvulsant drugs used in neonatal period.  
Phenytoin: is the second most commonly used drug as first line therapy for neonatal 
seizures. It is given as a loading dose of 20 mg/kg by slow intravenous infusion, not more 
than 1 mg / kg / minute followed by maintenance dose of 2-3 mg/kg/day intravenously in 
2-4 divided doses. The drug should not be dissolved in dextrose as it precipitated in it and 
the intravenous line should be washed with normal saline before given the medication if the 
neonate receiving glucose water. There should be a close monitoring of the cardiovascular 
system for arrhythmia and hypotension. One study compared the effectiveness of phenytoin 
and phenobarbitone in controlling neonatal seizures found no significant difference between 
www.intechopen.com
 Neonatal Seizures 39 
the two drugs (98). Another double blind prospective study shows phenytoin as effective in 
controlling neonatal seizures in 43% when use alone as first line drug and the efficacy is 
increased to 63% when combined with phenobarbitone (92). Furthermore, another study 
revealed that 30% of neonates continued to have electrographic seizures despite full loading 
doses of both phenytoin and phenobarbitone (99). Fosphenytoin is a prodrug of phenytoin 
has the advantages higher water solubility and lower pH, which, in addition to the lack of 
toxic vehicles required for its formulation, reduce local irritation of skin and blood vessel at 
the site of infusion, this will also avoid purple glove syndrome which represent the soft 
tissue necrosis and injury which occur with highly alkaline poorly soluble intravenous 
phenytoin (100). Fosphenytoin is converted to phenytoin by plasma phosphatase enzyme and 
it does not cause cardiac arrhythmia and hypotension to the same degree as phenytoin. 
Dose is calculated as equivalent to phenytoin and 1.5 mg/kg of Fosphenytoin is equal to 1 
mg/ kg of phenytoin.  
Benzodiazepines: some centers use acute administration of repeated doses of short acting 
benzodiazepines (diazepam, lorazepam and midazolam) as first line anticonvulsant therapy 
in a neonates with seizures because of their rapid onset of action but most centers use it as 
second or third line therapy because of their short half life, narrow therapeutic index and 
immediate cardiac respiratory and central nervous system depressive effect. These drugs are 
given intravenously ( or rectally in case of diazepam) and diazepam and midazolam are 
more effective when given by continuous intravenous infusion at which time the neonate 
should be monitored closely for cardio respiratory and CNS depression. Lorazepam is 
preferred over diazepam because of its longer duration of action and wider therapeutic 
index. Dose of diazepam is 0.3 mg/kg intravenously and 0.3 mg /kg/hour infusion rate 
when used by continuous infusion. Rectal rout might be used in a dose of 0.5 mg/kg. 
lorazepam is given by intravenous injection at a dose of 0.05 – 1 mg/kg over 2 – 5 minute 
while midazolam given as an initial loading dose of 0.15 mg/kg followed by continuous 
intravenous infusion at a rate of 0.1 – 1.4 mg/kg/hour.  
Alternative anticonvulsant therapy for refractory seizures: the majority of neonatal seizures will 
respond to the above mention drugs. Less than 10% are refractory to treatment and another 
group of anticonvulsant drugs are needed. Lidocaine may be effective in refractory seizures 
but its use is hampered by potential cardiac toxicity (101). Lidocaine drip given in an initial 
loading dose of 2 mg/kg given over 10 – 20 minutes followed by 4 – 6 mg /kg/hour in 
continuous drip. The drug has narrow therapeutic range and adverse effects include 
arrhythmia, hypotension and seizures if given in high doses. One study reports 4.8% 
incidence of cardiac arrhythmia, all of which is respond to Lidocaine discontinuation (102). 
Levetiracetam may also be effective in controlling neonatal seizures but there is little pediatric 
experience on its use in neonatal period, although a recent survey among pediatric 
neurologist suggests quite widespread off label use of Levetiracetam for refractory neonatal 
seizures despite lack of evidence on the safety, pharmacokinetics and efficacy of its use in 
neonates (103). Recent study use mean initial dose is 16 ± 6 mg/kg and the mean maximum 
dose is 45 ± 19 mg/kg/day. No respiratory or cardiovascular adverse effects were reported 
or detected. Levetiracetam was associated with a greater than 50% seizure reduction in  
35% (104).  
Other drugs that have been used orally as an adjunctive anticonvulsant therapy for 
controlling seizures in refractory cases include carbamazepine in a dose of 10 mg/kg initially 
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followed by 15 – 20 mg/kg/day. Also valproic acid can be used per rectally for acute 
condition and orally for maintenance therapy. Intravenous preparation of valproic acid is 
recently available. The dose is 20 -25 mg/kg/day followed by 5 – 10 mg/kg 12 hourly. The 
major risk of hepatotoxicity is more common in this age group which might occur at a rate 
of 1/500(42). Other drugs include primidone, felbamate, lamotrigine and vigabatrin. The efficacies 
of the above mention drugs can be difficult to assess since they are seldomly used as sole 
therapy for neonatal seizures and are usually given in conjunction with other anticonvulsant 
drugs. One study shows significant reduction in mean seizures duration and frequency 
following treatment of intractable multifocal neonatal seizures with the diuretic bumetainde 
with no associated clinical side effect or metabolic imbalance (105). Another study found 
bumetainde to enhance the anticonvulsant action of phenobarbitone in immature brain by 
alteration of Cl- transport. Seizures were abolished in 70% and significantly reduced the 
frequency, duration and power of seizures in the remaining 30% when both drugs used in 
conjunction (106). 
Maintenance therapy: there are no consensuses guideline exist regarding the duration of 
keeping an infant on anticonvulsant therapy after a neonatal seizures (107, 108, 109). The 
principle is to keep the infant for the shortest possible time on anticonvulsant therapy. The 
duration is variable according to the underlying etiology, neurological examination and 
EEG changes. The most widely accepted drug for maintenance therapy is phenobarbitone in 
a dose of 3 – 5 mg/kg/day in one or two divided doses with monitoring serum level. 
Phenytoin is an alternative therapy. Volpe (110) adopt a protocol recommend discontinuation 
of all medication at discharge if the neonate is neurologically normal, regardless the etiology 
and EEG findings. If the neurological examination is abnormal on discharge, the neonate 
kept on anticonvulsant therapy and reassessed at one month age. At the age of one month, if 
the neurological examination is normal and the infant has no further seizures, the 
phenobarbitone is weaned over two weeks. If the neurological assessment is abnormal, an 
EEG is obtained. If the EEG is normal, the drug is tapered and stopped but if the EEG is 
abnormal, the infant continue on his anticonvulsant and reassess every 3 months till the age 
of one year in the same manner. Another protocol recommends drug withdrawal 2 weeks 
after the infant last seizures (111) after doing EEG to exclude subclinical seizures.  
9. Prognosis  
Seizures in early life may results in permanent anatomical and functional alteration and 
enhance epileptogenicity (112, 113). The long term outcome of neonatal seizures is determined 
by many factors including the underlying etiology of the seizure, seizure type and duration 
and the EEG findings. Hypocalcemia and benign familial neonatal seizures are associated 
with excellent prognosis regarding survival and long term sequel in contrast to symptomatic 
hypoglycemia, intracranial hemorrhage, meningitis and hypoxic ischemic encephalopathy 
which are associated with high mortality rate and high incidence of long term complication 
as epilepsy, mental retardation, and various neurological disorders. Short lived, easily 
controlled seizures are associated with favorable outcome probably because they may reflect 
transient benign CNS disorder while sustained refractory seizures, on the other hand, 
reflects more severe brain disorder. Focal clonic and focal tonic seizures where associated 
with a relatively good outcome, while generalized tonic posturing and motor automatisms 
where associated with a poor out come. This probably reflects the underlying etiology and 
the extent of brain dysfunction (85, 114). A relationship has been shown in infants with 
neonatal seizures, associated with perinatal asphyxia, between a great amount of 
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electrographic seizures activity and subsequent relative increased morbidity and mortality 
(115, 116). Many studies shows a mortality rate ranging from 7 to 30% , variable percentage of 
mental retardation and neurological abnormalities of different severity and post neonatal 
epilepsies in up to 56% in infants with severe brain injury( 116-120). In a population based 
study by Ronen between 1990 and 1994, a 62 term and 26 preterm newborn with neonatal 
seizures where followed comprehensively. Only 35% were a live and without disability. 
Twenty four percent of children died and of the survival, 41% had one of epilepsy, mental 
retardation, cerebral palsy or learning disability (121). A scoring system to predict the 
neurological outcome at the onset of neonatal seizures was tested on 106 newborn with 
neonatal seizures between 1999 and 2004. This system used 6 variables including birth 
weight, Apgar score at one minute, neurological examination at the onset of the seizures, 
cerebral ultrasound, efficacy of anticonvulsant therapy and the presence of neonatal status 
epilepticus. This system found to be an easy, rapid and reliable prognostic indicator of 
neurological outcome after the onset of neonatal seizures (122).  
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